Categories AlphaGraphs, Earnings, Health Care
Abbott Laboratories (ABT) Q2 2024 Earnings: Key financials and quarterly highlights
Abbott Laboratories (NYSE: ABT) reported second quarter 2024 earnings results today.
Net sales increased 4% year-over-year to $10.4 billion.
Net earnings decreased 5% to $1.3 billion, or $0.74 per share, compared to last year. Adjusted EPS rose 5.6% to $1.14.
Abbott expects GAAP EPS of $3.30-3.40 and adjusted EPS of $4.61-4.71 for the full year of 2024.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Netflix (NFLX) stands tall in a heavily competitive streaming landscape
Shares of Netflix, Inc. (NASDAQ: NFLX) were down over 2% on Friday. The stock has gained 27% over the past three months. The streaming giant continues to hold its ground
Starbucks (SBUX): A look at the challenges that continue to beleaguer the coffee giant
Shares of Starbucks Corporation (NASDAQ: SBUX) rose 2% on Thursday. The stock has dropped 9% over the past month. The company has faced its fair share of challenges during fiscal
Broadcom (AVGO) thrives on growing AI business. Is the stock a buy?
Broadcom, Inc. (NASDAQ: AVGO), a leading provider of semiconductor solutions for wired and wireless communications, recently impressed the market with upbeat financial outlook highlighting strong prospects for its AI business
